GLDC

glycine decarboxylase

Basic information

Region (hg38): 9:6532467-6645729

Links

ENSG00000178445NCBI:2731OMIM:238300HGNC:4313Uniprot:P23378AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • glycine encephalopathy (Definitive), mode of inheritance: AR
  • glycine encephalopathy (Strong), mode of inheritance: AR
  • neonatal glycine encephalopathy (Supportive), mode of inheritance: AR
  • infantile glycine encephalopathy (Supportive), mode of inheritance: AR
  • atypical glycine encephalopathy (Supportive), mode of inheritance: Unknown
  • glycine encephalopathy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glycine encephalopathy 1ARBiochemicalTreatment may be less effective for individuals with severe disease; however, aggressive early treatment with sodium benzoate and N-methyl D-aspartate receptor site antagonists in individuals with variants associated with residual GCS enzyme activity have been reported to result in improved outcomesBiochemical; Neurologic; Ophthalmologic10873393; 12402263; 15077252; 15236413; 15851735; 16151895; 16404748; 16450403; 17361008; 20301531; 20933183; 21411353; 23349517

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GLDC gene.

  • Glycine encephalopathy (149 variants)
  • Glycine encephalopathy 1 (10 variants)
  • not provided (9 variants)
  • GLDC-related disorder (4 variants)
  • Inborn genetic diseases (2 variants)
  • Smith-Magenis Syndrome-like (1 variants)
  • Generalized epilepsy;Obesity;Global developmental delay (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GLDC gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
589
clinvar
8
clinvar
600
missense
28
clinvar
75
clinvar
545
clinvar
17
clinvar
1
clinvar
666
nonsense
46
clinvar
56
clinvar
2
clinvar
104
start loss
2
clinvar
2
frameshift
52
clinvar
41
clinvar
93
inframe indel
1
clinvar
1
clinvar
6
clinvar
8
splice donor/acceptor (+/-2bp)
21
clinvar
41
clinvar
2
clinvar
64
splice region
1
6
36
121
1
165
non coding
16
clinvar
386
clinvar
95
clinvar
497
Total 150 214 574 992 104

Highest pathogenic variant AF is 0.0000855

Variants in GLDC

This is a list of pathogenic ClinVar variants found in the GLDC region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-6532471-G-A Glycine encephalopathy Uncertain significance (Jan 13, 2018)367161
9-6532477-G-A Glycine encephalopathy Benign (Jan 13, 2018)367162
9-6532510-TAA-T Glycine encephalopathy Uncertain significance (Jun 14, 2016)367163
9-6532521-A-C Glycine encephalopathy Uncertain significance (Jan 13, 2018)915251
9-6532544-G-A Glycine encephalopathy Benign (Jan 13, 2018)367164
9-6532607-C-G Glycine encephalopathy Benign (Jan 12, 2018)367165
9-6532607-C-T Glycine encephalopathy Uncertain significance (Jan 12, 2018)915252
9-6532639-C-A Glycine encephalopathy Uncertain significance (Jan 12, 2018)912559
9-6532672-C-A Glycine encephalopathy Uncertain significance (Jan 13, 2018)912560
9-6532760-C-T Glycine encephalopathy Likely benign (Jul 26, 2018)367166
9-6532781-C-A Glycine encephalopathy Likely benign (Jan 12, 2018)912561
9-6532782-A-C Glycine encephalopathy Uncertain significance (Jan 12, 2018)367167
9-6532788-G-C Glycine encephalopathy Likely benign (Jan 13, 2018)912562
9-6532829-G-A Glycine encephalopathy Uncertain significance (Jan 13, 2018)367168
9-6532855-C-T Likely benign (Aug 25, 2018)1219985
9-6532902-T-A Glycine encephalopathy Uncertain significance (Jan 13, 2018)367169
9-6533010-C-G not specified • Glycine encephalopathy Benign (Jul 10, 2021)255452
9-6533012-G-C Glycine encephalopathy Uncertain significance (Apr 06, 2018)367170
9-6533018-TA-T Glycine encephalopathy Uncertain significance (Jul 15, 2022)2017286
9-6533023-A-T Glycine encephalopathy Likely benign (Feb 18, 2020)1090565
9-6533026-C-T Glycine encephalopathy Likely benign (Jan 12, 2024)1116159
9-6533027-G-A Glycine encephalopathy Uncertain significance (May 03, 2022)2194919
9-6533030-C-A Glycine encephalopathy Uncertain significance (Oct 24, 2021)1345532
9-6533030-C-T Glycine encephalopathy Uncertain significance (Jan 14, 2022)1362239
9-6533032-C-G Glycine encephalopathy Uncertain significance (Feb 01, 2023)1514032

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GLDCprotein_codingprotein_codingENST00000321612 25113187
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.58e-280.0023812563901091257480.000434
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.596455411.190.00003036656
Missense in Polyphen256245.661.04212936
Synonymous-4.812922051.430.00001241961
Loss of Function0.9134653.20.8650.00000292645

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007200.000720
Ashkenazi Jewish0.0001990.000198
East Asian0.0002180.000217
Finnish0.0001850.000185
European (Non-Finnish)0.0005910.000589
Middle Eastern0.0002180.000217
South Asian0.0004260.000425
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: The glycine cleavage system catalyzes the degradation of glycine. The P protein (GLDC) binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein (GCSH). {ECO:0000269|PubMed:1993704, ECO:0000269|PubMed:1996985, ECO:0000269|PubMed:28244183}.;
Disease
DISEASE: Non-ketotic hyperglycinemia (NKH) [MIM:605899]: Autosomal recessive disease characterized by accumulation of a large amount of glycine in body fluid and by severe neurological symptoms. {ECO:0000269|PubMed:11286506, ECO:0000269|PubMed:11592811, ECO:0000269|PubMed:1634607, ECO:0000269|PubMed:1996985, ECO:0000269|PubMed:28244183, ECO:0000269|PubMed:28737873}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Glycine, serine and threonine metabolism - Homo sapiens (human);Glyoxylate and dicarboxylate metabolism - Homo sapiens (human);3-Phosphoglycerate dehydrogenase deficiency;Non Ketotic Hyperglycinemia;Ammonia Recycling;Glycine and Serine Metabolism;Dimethylglycine Dehydrogenase Deficiency;Hyperglycinemia, non-ketotic;Dimethylglycine Dehydrogenase Deficiency;Sarcosinemia;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Glycine degradation;Metabolism of amino acids and derivatives;Glycine Serine metabolism;Metabolism;Glyoxylate metabolism and glycine degradation;Glycine, serine, alanine and threonine metabolism;glycine cleavage (Consensus)

Recessive Scores

pRec
0.312

Intolerance Scores

loftool
0.0943
rvis_EVS
-0.67
rvis_percentile_EVS
15.41

Haploinsufficiency Scores

pHI
0.551
hipred
N
hipred_score
0.441
ghis
0.527

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.918

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gldc
Phenotype
renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
glycine catabolic process;glycine decarboxylation via glycine cleavage system;electron transport chain;response to methylamine;response to lipoic acid;cellular response to leukemia inhibitory factor
Cellular component
nucleus;mitochondrion;mitochondrial matrix;plasma membrane;glycine cleavage complex
Molecular function
glycine dehydrogenase (decarboxylating) activity;electron transfer activity;glycine binding;lyase activity;enzyme binding;pyridoxal phosphate binding;protein homodimerization activity;pyridoxal binding